(Q40088637)
English
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia
scientific article published on 16 January 2016
Statements
1 reference
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia (English)
1 reference
Stacey Zahler
Monica Bhatia
Angela Ricci
Erin Morris
Lauren Harrison
Carmella van de Ven
Sandra Fabricatore
Karen Wolownik
Erin Cooney-Qualter
Lee Ann Baxter-Lowe
Paul Luisi
Olga Militano
Morris Kletzel
16 January 2016
1 reference